Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by HonestAbeon Mar 18, 2013 10:44am
197 Views
Post# 21145160

RE: RE: RE: RE: RE: RE: Observation & Suggestion

RE: RE: RE: RE: RE: RE: Observation & Suggestion

hrattle, if my posting of my trade "offended" you then just ignore it.  I was merely adding more detail in reply to lol_lol reply to my Mar 11th post where I stated that there was a very high probability that BRD would spike up to possibly 85 cents (50-day MA) since many other gold stocks had done so by that time and BRD was still stuck in the low to mid-70's.  I pointed that out well BEFORE that event occurred.  I actually had a sell order in at 86 cents since that was actually the exact 50-day MA price at the time and had to modify it 2 cents lower when the action stalled and not even one taker for 85 cents.

 

I already profited from several other gold stocks doing this recent spike including TMM (got out a bit too early) and MDW on traders and now you can add BRD to the list.  I have also mentioned for a very long time that the strategy, until it changes, is to SELL ALL RALLIES in BRD!  Otherwise, how else has anyone here made any money on a stock that is trading near its 52-week low???

 

Anyways, I will only make the odd occassional post in BRD and not suggest any more price points or even list any of my trades because I would hate to "offend" anyone else on this board!  ;)

Bullboard Posts